Evaluation of Physical Exercise to Prevent Functional Deterioration During Hospitalization (EFFAPRO) (EFFAPRO)

March 4, 2022 updated by: Ana Ruiz-Casado, Puerta de Hierro University Hospital

Evaluation of Physical Exercise as a Protective Factor for the Loss of Functional Capacity in Patients With Metastatic Tumors During Hospitalization. Pilot Study (EFFAPRO)

This is a randomized study that will measure the possible benefit of supervised training during the hospitalization of patients with stage IV neoplasms in active treatment.

Study Overview

Status

Withdrawn

Intervention / Treatment

Detailed Description

The trial is not going to be runned

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Majadahonda, Madrid, Spain, 28222
        • Hospital Universitario Puerta de Hierro

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with stage IV neoplasms.
  • Active treatment: chemotherapy, hormone therapy, immunotherapy or targeted therapies.
  • Hospitalization at Medical Oncology Departmentof the Hospital Puerta de Hierro.
  • Reason for hospitalization is expected to be solved in less than two weeks.

Exclusion Criteria:

  • Patients who do not wish to participate.
  • Cognitive impairment.
  • Hospitalization due to progression of oncological disease.
  • Acute coronary syndrome or bone fracture in limbs during the previous three months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Supervised physical exercise
Supervised exercise (aerobic + strength + flexibility) depending on the functional capacity of each patient, during hospitalization
A supervised exercise is randomized. Although this intervention is not standard in our setting, it is a recommended practice, since it is known that rehabilitation strategies in hospitalized patients have different benefits.
No Intervention: Control
Patients will receive recommendations about exercising during hospitalization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional capacity
Time Frame: Through study completion (average 10 days)
Functional Independence Measure (FIM)
Through study completion (average 10 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength
Time Frame: Through study completion (average 10 days).
Dynamometry
Through study completion (average 10 days).
Cardiorespiratory condition
Time Frame: Through study completion (average 10 days)
Six minute test .
Through study completion (average 10 days)
Daily physical activity
Time Frame: Through study completion (average 10 days)
Accelerometry during the hospitalization.
Through study completion (average 10 days)
Fatigue-FACIT
Time Frame: Through study completion (average 10 days)
FACIT Fatigue Scale
Through study completion (average 10 days)
Fatigue-PERFORM
Time Frame: Through study completion (average 10 days)
PERFORM Fatigue questionnaire (12-60) Higher, better (less fatigue)
Through study completion (average 10 days)
Life quality: Q30 questionnaire
Time Frame: Through study completion (average 10 days)
QLQ30 questionnaire (quality of life). 0-100 (HIGHER, better)
Through study completion (average 10 days)
Anxiety and depression
Time Frame: Through study completion (average 10 days)
HADS questionnaire (anxiety and depression). 0-42 (less better)
Through study completion (average 10 days)
Length of hospital stay
Time Frame: Through study completion (average 10 days).
Number of days the patient is hospitalized.
Through study completion (average 10 days).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ana Ruiz Casado, Puerta de Hierro University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 28, 2018

Primary Completion (Actual)

August 28, 2018

Study Completion (Actual)

August 28, 2018

Study Registration Dates

First Submitted

August 27, 2018

First Submitted That Met QC Criteria

March 4, 2022

First Posted (Actual)

March 16, 2022

Study Record Updates

Last Update Posted (Actual)

March 16, 2022

Last Update Submitted That Met QC Criteria

March 4, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PH-07

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Patients

Clinical Trials on Supervised physical exercise

3
Subscribe